Clinical Trial Update: Creatine for the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating creatine for the treatment of Amyotrophic Lateral Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED